
About this show
Facts, data, and analytics about biomedical matters.
erictopol.substack.com (https://erictopol.substack.com/s/podcasts?utm_medium=podcast)
Show details and episodes come from the publisher's public feed at api.substack.com. Last updated . Names, artwork and text belong to their publishers.
Cosmos
Similar by topic and creator
- In the Interim...
Shares the topics Health and Science. - Risky or Not?
Shares the topics Health and Science. - Rain Sounds - 10 Hours
Shares the topics Health and Science.
Episodes
Sir John Bell: Transforming Life Science and Medicine's Future
· 33 min
Audio File Ground Truths can also be found on Apple Podcasts, Spotify and YouTube. The UK is the world leader in human genomics, and laid the foundation for advancing medicine with the UK Biobank, Genomes England and now Our Future Health (w/ 5 million participants). Sir John Bell is a major force in driving and advising these and many other initiatives. After 22 years as the Regius Professor of Medicine at the University of Oxford he left in 2024 to be President of the Ellison Institute of Technology. Professor Bell has been duly recognized in the UK: knighted in 2015 and appointed Companion of Honor in 2023. In our conversation, you will get a sense for how EIT will be transformational for using A.I. and life science for promoting human health. Transcript with audio links Eric Topol (00:06 (https://www.rev.com/transcript-editor/shared/Lb-HGAVlBiTAQAYwjiDPRSAlzByX9h0X1eBALLOg8rSZ2arvp_m8G2dSddhrKijmKM1K_-h6N7iIA5UHPL49RTOijmE?loadFrom=DocumentDeeplink&ts=6.2699999)): Hello, this is Eric Topol from Ground Truths. And I'm really delighted to welcome today, Sir John Bell who had an extraordinary career as a geneticist, immunologist, we'll talk about several initiatives he's been involved with during his long tenure at University of Oxford, recently became head of the Ellison Institute of Technology (EIT) (https://www.eit.org/) in the UK. So welcome, John. Sir John Bell (00:30 (https://www.rev.com/transcript-editor/shared/y64ABJm7W-VpEqepvETvmiBRL-m8y8-DmeEjwS7ZalSc37r-nrxY3i7c0K-SrdM8GwZWWRrj5xe75tJ9wxZhbFl_izc?loadFrom=DocumentDeeplink&ts=30.6)): Thanks, Eric. Thanks very much for having me. Eric Topol (00:34 (https://www.rev.com/transcript-editor/shared/AJMnDyDTRYcsL8-ONqYnTB1dNfgMmWHPJ_ighVRIqvgVWw3EUa-aYozysUUStQz7Lq4LqVI8gs9sHLeAxQWOS-MBIv4?loadFrom=DocumentDeeplink&ts=34.14)): Well, I think it's just extraordinary the contributions that you have made and continue to make to advance medicine, and I thought what we could do is get into that. I mean, what's interesting, you have had some notable migrations over your career, I think starting in Canada, at Stanford, then over as Rhodes Scholar in Oxford. And then you of course had a couple of decades in a very prestigious position, which as I understand was started in 1546 by King Henry VII, and served as the Regius Professor of Medicine at the University of Oxford. Do I have that right? Sir John Bell (01:11 (https://www.rev.com/transcript-editor/shared/OTnnRLS9LqP8k0hWIbv-ciS9pCa_JxrMiVjhi_aaiZaunw_AQ2UhLqztumkmdBh2FirE-frItBU4dNu2RgZFyMEIuSQ?loadFrom=DocumentDeeplink&ts=71.22)): It was actually Henry VIII, but you were close. Eric Topol (01:14 (https://www.rev.com/transcript-editor/shared/laS0e5J936_poo0-vS6O_4pA7iSjFpT_XhE5Vq0up4GwbXqrzMgfv6CQB7eDEMcpjMOtjTWGlV9KUVCiGemBEKbcKHI?loadFrom=DocumentDeeplink&ts=74.49)): Henry VIII, that's great. Yeah. Okay, good. Well, that's a pretty notable professorship. And then of course in recent times you left to head up this pretty formidable new institute, which is something that's a big trend going on around the world, particularly in the US and we'll talk about. So maybe we can start with the new thing. Tell us more about the Ellison Institute of Technology (EIT), if you will. Sir John Bell (01:47 (https://www.rev.com/transcript-editor/shared/zUs26v83CL608mTxFD_PTxMlaueGY0xAQ3Gao7woJPkXgDhmkcLS1ylsEZbO37B1SiN1uER4wVx0XJruxIzUksmbq2E?loadFrom=DocumentDeeplink&ts=107.82)): Yeah. So as you know, Larry Ellison has been one of the great tech entrepreneurs focused really on developing terrific databases over his career and through Oracle, which is the company that he founded. And Larry is really keen to try and give back something substantial to the world, which is based on science and technology. So he and I did quite a bit together over the Covid pandemic. He and I talked a lot about what we're doing and so on. He came to visit afterwards and he had, I think he decided that the right way to make his contributions would be…
Not rated yetTyler Cowen: The Prototypic Polymath
· 32 min
Audio file, also on Apple and Spotify Tyler Cowen, Ph.D, is the Holbert L. Harris Professor of Economics at George Mason University. He is the author of 17 books, most recently Talent.: How to Identify Energizers, Creatives, and Winners Around the World. Tyler has been recognized as one of the most influential economists of the past decade. He initiated and directs the philanthropic project Emergent Ventures (https://www.mercatus.org/emergent-ventures), writes a blog Marginal Revolution (https://marginalrevolution.com/), and a podcast Conversations With Tyler (https://conversationswithtyler.com), and also writes columns for The Free Press (https://www.thefp.com/w/tyler-cowen)." He is writing a new book (and perhaps his last) on Mentors. “Maybe AGI [Artificial General Intelligence] is like porn — I know it when I see it. And I’ve seen it.”—Tyler Cowen Our conversation on acquiring information, A.I., A.G.I., the NIH, the assault on science, the role of doctors in the A.I. era,, the meaning of life, books of the future, and much more. Transcript with links Eric Topol (00:06 (https://www.rev.com/transcript-editor/shared/xVsMlSIPZY4F-cGyAdP_SEQC5U07NIeaoGtt_yjNV-RjhN50MKxGIK2-3bLz-bMNkX99fFSHkMkCTEo9gS8ZFmpJgrU?loadFrom=DocumentDeeplink&ts=6.15)): Well, hello. This is Eric Topol with Ground Truths, and I am really thrilled today to have the chance to have a conversation with Tyler Cowen, who is, when you look up polymath in the dictionary, you might see a picture of him. He is into everything. And recently in the Economist magazine 1843, John Phipps wrote a great piece profile, the man who wants to know everything (https://www.economist.com/1843/2025/02/28/tyler-cowen-the-man-who-wants-to-know-everything). And actually, I think there's a lot to that. Tyler Cowen (00:36 (https://www.rev.com/transcript-editor/shared/OEzJknGUpsSEwqpOLWBSwPZWa2XWU7LUYzf6dIRSGLCvqM3Hk3aFfSppO5lfc7ylki36GPD2T36hwRYcDtjAySNVkZM?loadFrom=DocumentDeeplink&ts=36.54)): That's why we need longevity work, right? Eric Topol (00:39 (https://www.rev.com/transcript-editor/shared/nguvIN_w2w1oA1R8mrLJo2hJyJ-S2uCawZNfRMoN2ThlBRusHqXBAyqbdoxLoWkg0LfLOw966yU_oV2_BqHMaViK0-s?loadFrom=DocumentDeeplink&ts=39.06)): Right. So he's written a number of books. How many books now, Tyler? Tyler Cowen: 17, I'm not sure. Eric Topol: Only 17? And he also has a blog that's been going on for over 20 years, Marginal Revolution (https://marginalrevolution.com/) that he does with Alex Tabarrok. Tyler Cowen (00:57 (https://www.rev.com/transcript-editor/shared/tcjHazIh4QsOBus8Uq_L1kq2b6MSVkjLM9IoSRrMxbiqqdoYde7xYonKXvXUIhL_O9RSdN9VJD-CxTYKTjAh8mDUJVY?loadFrom=DocumentDeeplink&ts=57.06)): Correct. Eric Topol (00:57 (https://www.rev.com/transcript-editor/shared/Cf9O9jUdOMSKYoa18tQt5TYD_M-dYFs7JMOnhNps1e1nxOkhlf6yUQLuiIjojYY4NKAWdzzdLxuetfcrqBDChwEXD98?loadFrom=DocumentDeeplink&ts=57.51)): And yeah, and thenConversations with Tyler, a podcast, (https://conversationswithtyler.com/) which I think an awful lot of people are tuned into that. So with that, I'm just thrilled to get a chance to talk with you because I used to think I read a lot, but then I learned about you. “Cowen calls himself “hyperlexic”. On a good day, he claims to read four or five books. Secretly, I timed him at 30 seconds per page reading a dense tract by Martin Luther. “—John Phipps, The Economist’s 1843 I've been reading more from the AIs lately and less from books. So I'll get one good book and ask the AI a lot of questions. Eric Topol (01:24 (https://www.rev.com/transcript-editor/shared/V0FLnYwDBgyMsE3vSyTErN8b-5DtZ2Mc1e53hPcOFZTuUIM3v4BHgvXrGCBlg2wE1FFukS2CpcM_r5SwVap-di02HfA?loadFrom=DocumentDeeplink&ts=84.9599999)): Yeah. Well, do you use NotebookLM for that? Tyler Cowen (01:28 (https://www.rev.com/transcript-editor/shared/QyZ-jSZ3fdxd2BGUo0DF9n3FWTMOcvZ4HUmSSLsUHHGXJ4es1tvk01MqDYhNaWw7xjH4xxtkqCn3XFt4-kYWJRLEAPM?loadFrom=DocumentDeeplink&ts=88.83)): No, just o3 from OpenAI at the moment,…
Not rated yetBob Bordone and Joel Salinas: How to Deal With Conflict
· 29 min
In our divided world we face or avoid conflicts on a frequent basis. I turned to Bob Bordone and Joel Salinas to find out the best strategies to deal with these, including having them take on a mock conflict between each other on the merits of Covid research. Audio file You can also find this on Spotify and Apple podcasts with Ground Truths. The video is also posted on YouTube Transcript with Audio Links Eric Topol (00:06 (https://www.rev.com/transcript-editor/shared/sK989Hzn6Y584GwM9bqQdCnZHFkqt1Z6SQhgToNX3a65BlQgBXZhYbTqXYiVwi1nZTezZXaWwnbcA3h0OAgTEcbgJyk?loadFrom=DocumentDeeplink&ts=6.57)): Well, hello. It's Eric Topol with Ground Truths, and we're going to get into a new book called Conflict Resilience: Negotiating Disagreement Without Giving Up or Giving In (https://www.harpercollins.com/products/conflict-resilience-robert-bordonejoel-salinas?variant=42778535854114), and we're lucky to have its two authors, Bob Bordone, who is a Senior Fellow at Harvard Law School, and Joel Salinas, who is a physician, neurologist, a clinician scientist at NYU. So welcome both Bob and Joel. Bob Bordone and Joel Salinas (00:34 (https://www.rev.com/transcript-editor/shared/H_1-9zyA6n6wab0FTJ8ym9s5Ajrg4GMnvSGfPt-lxEE7lvc73XnBlHFqBjxJhO8yG3D2lcXushutcXtFbxu7TH0VmkQ?loadFrom=DocumentDeeplink&ts=34.89)): Thank you for having us. Yeah, looking forward to the conversation. Eric Topol (00:37 (https://www.rev.com/transcript-editor/shared/IcbPC9wC2aG9X-rJHxsrLnIcgzbJpnHWlVLM0O80Fgq-g750PyYzuTneuyf28sXaNdG_HKFmEpu6pPTNeKopASZnmdI?loadFrom=DocumentDeeplink&ts=37.2299999)): Yeah. So first, how did you guys get together? This is a pretty diverse, you got law and medicine, usually they don't talk to each other very much. Bob Bordone (00:46 (https://www.rev.com/transcript-editor/shared/YVI2r3wcUw2EgSeZgLlb3w8gJ-R-RmfRHgPHPC7v1mApJsgtSaJvn8G6GsEd2W39M66gDqlJbgGzXXLFIUHk_d0f4HI?loadFrom=DocumentDeeplink&ts=46.86)): Well, we were very fortunate. I mean, we basically were friends, but part of that friendship, I think emerged from work that I do around conflict issues in the Mass General system and then just the larger, bigger Mass General, Harvard community. Yeah, so this began really as a friendship where we were each swimming in very different waters, but then as we would start to talk, we realized there was a lot of connection and maybe the possibility to bring two different disciplines together in a way that might be practically useful and make an impact. And even when we started writing this, which was during Covid, what seemed to be some pretty polarizing times that were unlikely to resolve by the time the book would come out. Eric Topol (01:44 (https://www.rev.com/transcript-editor/shared/3B8e-Tzp4apr8eUiGe6SWGbU8i_uR6AF2Q1L5lpE6p8umkk7WRMlocGivJBPjElvo0K9wwTFYY3riQEkI9DKjffKB6Y?loadFrom=DocumentDeeplink&ts=104.55)): Yeah, well you sure hit it with the divisiveness and the polarized world that we live in is perhaps worse than ever, certainly in all my years, and probably long before then as well. So this topic of resilience, it's a very interesting concept because some people might think of resilience as just being tough. So go into a conflict and just go heavy tough. That obviously is not what you're writing about. And I guess maybe we can start off, what was the goal here? Obviously, there's other books that have addressed this topic, I'm sure, but yours is somewhat unique in many respects because it brings in the science of it and many strategies perhaps that have never been developed. But when you got together, what was the mission that you set out to do? Joel Salinas (02:38 (https://www.rev.com/transcript-editor/shared/Qe_KhySwLqPXM6TfLWmdT9f_HUa28SozhhF0npsJFZDrWI6EJMnhJT4TxsfhNS54r3btwd5JSk5F9egon7-vl5vi_hc?loadFrom=DocumentDeeplink&ts=158.76)): Yeah, well maybe I can start out and then you can add on. So my research has been all around understanding how social relationships influenced brain health, and one of the things that I…
Not rated yetSteve Quake and Charlotte Bunne: The Holy Grail of Biology
· 43 min
“Eventually, my dream would be to simulate a virtual cell.” (https://keywordkings.com.au/ai-unites-davos-dc/)—Demis Hassabis The aspiration to build the virtual cell is considered to be equivalent to a moonshot for digital biology. Recently, 42 leading life scientists published a paper in Cell on why this is so vital, and how it may ultimately be accomplished. This conversation is with 2 of the authors, Charlotte Bunne, now at EPFL (https://www.epfl.ch/en/) and Steve Quake, a Professor at Stanford University, who heads up science at the Chan-Zuckerberg Initiative (https://chanzuckerberg.com) The audio (above) is available on iTunes and Spotify. The full video is linked here, at the top, and also can be found on YouTube (https://www.youtube.com/@EricTopolSRTI). TRANSCRIPT WITH LINKS TO AUDIO Eric Topol (00:06 (https://www.rev.com/transcript-editor/shared/6lGiRjXlDOpQrUiaME8yoorb9jlNKtlo6P8J7gWmdWRUxFy-RDAOLfStR_gIJ1W2iXgSxTJj0Alc1BOKCd31tNn8n20?loadFrom=DocumentDeeplink&ts=6.9)): Hello, it's Eric Topol with Ground Truths and we've got a really hot topic today, the virtual cell. And what I think is extraordinarily important futuristic paper that recently appeared in the journal Cell and the first author, Charlotte Bunne from EPFL, previously at Stanford’s Computer Science. And Steve Quake, a young friend of mine for many years who heads up the Chan Zuckerberg Initiative (CZI) as well as a professor at Stanford. So welcome, Charlotte and Steve. Steve Quake (00:42 (https://www.rev.com/transcript-editor/shared/C1KZkE6NiJskhZCIPyzrDRuWMiRRY5fVGXlVX7eAiCqNfcvDkkz26s3_CvzL-C5WKSwPSL9gQrnTMpX2GjDnRBu6Gp8?loadFrom=DocumentDeeplink&ts=42.51)): Thanks, Eric. It's great to be here. Charlotte Bunne: Thanks for having me. Eric Topol (00:45 (https://www.rev.com/transcript-editor/shared/UJvnPOFFEOkamloMV9g2rQuxv0_L_rggLNpTSqNdDPG7QTDBiwbI8TP7o6uuFSB3m_0FZGkPBy4eH1ESHjcfnS4w8bs?loadFrom=DocumentDeeplink&ts=45.69)): Yeah. So you wrote this article that Charlotte, the first author, and Steve, one of the senior authors, appeared in Cell in December and it just grabbed me, “How to build the virtual cell with artificial intelligence: Priorities and opportunities (https://www.cell.com/cell/fulltext/S0092-8674(24)01332-1).” It's the holy grail of biology. We're in this era of digital biology and as you point out in the paper, it's a convergence of what's happening in AI, which is just moving at a velocity that's just so extraordinary and what's happening in biology. So maybe we can start off by, you had some 42 authors that I assume they congregated for a conference or something or how did you get 42 people to agree to the words in this paper? Steve Quake (01:33 (https://www.rev.com/transcript-editor/shared/IVhxpeLP7e0LM0PFKwZt3HIuOvIbcwgO-lenyW0NnHnIju_rICaQ75wykRKr8emzrm10z6YzmGxcWEgjS56hwmdoKHQ?loadFrom=DocumentDeeplink&ts=93.03)): We did. We had a meeting at CZI to bring community members together from many different parts of the community, from computer science to bioinformatics, AI experts, biologists who don't trust any of this. We wanted to have some real contrarians in the mix as well and have them have a conversation together about is there an opportunity here? What's the shape of it? What's realistic to expect? And that was sort of the genesis of the article. Eric Topol (02:02 (https://www.rev.com/transcript-editor/shared/nila3BSEuh7dj_xV-tcdYbRBmNGW_8QJ864Ru9jxIylGEI-x-1BPUUXiRLB1rPhaw0wi9pvPLPO4dwjImstPXYsGI7I?loadFrom=DocumentDeeplink&ts=122.91)): And Charlotte, how did you get to be drafting the paper? Charlotte Bunne (02:09 (https://www.rev.com/transcript-editor/shared/0HToibBz1w0mr-vqcMkoPpRm87lsuHbgB1m2aeunGioP772zWJ1RsfM03SVSKw6T8tPfs-EDVFqc6RCOaz3V9dwctpM?loadFrom=DocumentDeeplink&ts=129.63)): So I did my postdoc with Aviv Regev at Genentech and Jure Leskovec at CZI and Jure was part of the residency program of CZI. And so, this is how we got involved and you had also prior work with Steve on the universal cell…
Not rated yetKatelyn Jetelina: Public health in the US
· 26 min
Thank you Katelyn Jetelina (https://substack.com/profile/27227002-katelyn-jetelina), Andy Meyers (https://substack.com/profile/17296353-andy-meyers), Tracy Paeschke, MD, FACC (https://substack.com/profile/41161758-tracy-paeschke-md-facc), Bruce Lanphear (https://substack.com/profile/17782996-bruce-lanphear), Tay MacIntyre (https://substack.com/profile/3378775-tay-macintyre), and many others for tuning into my live video with Katelyn Jetelina (https://substack.com/profile/27227002-katelyn-jetelina)! Join me for my next live video in the app. Get full access to Ground Truths at erictopol.substack.com/subscribe (https://erictopol.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4)
Not rated yetAnna Greka: Molecular Sleuthing for Rare Diseases
· 48 min
Funding for the NIH and US biomedical research is imperiled at a momentous time of progress. Exemplifying this is the work of Dr. Anna Greka, a leading physician-scientist at the Broad Institute who is devoted to unlocking the mysteries of rare diseases— that cumulatively affect 30 million Americans— and finding cures, science supported by the NIH. A clip from our conversation The audio is available on iTunes and Spotify. The full video is linked here, at the top, and also can be found on YouTube (https://www.youtube.com/@EricTopolSRTI). Transcript with audio and external links Eric Topol (00:06 (https://www.rev.com/transcript-editor/shared/jX0HV4tQ3lhFMybeklNOx6GAL8uAuxgksDgEUtbngMZBFeWiEVU96S9YfN2WHyR4yCeg0Qu-fTyyun-ETCwweOiEAIY?loadFrom=DocumentDeeplink&ts=6.78)): Well, hello. This is Eric Topol from Ground Truths, and I am really delighted to welcome today, Anna Greka. Anna is the president of the American Society for Clinical Investigation (ASCI) this year, a very prestigious organization, but she's also at Mass General Brigham, a nephrologist, a cell biologist, a physician-scientist, a Core Institute Member of the Broad Institute of MIT and Harvard, and serves as a member of the institute’s Executive Leadership Team. So we got a lot to talk about of all these different things you do. You must be pretty darn unique, Anna, because I don't know any cell biologists, nephrologists, physician-scientist like you. Anna Greka (00:48 (https://www.rev.com/transcript-editor/shared/y9YUqBVcN8XW4gq6MYmBhZ_TmoLoxgOmPMd88gbgtEhbmGw1vlIba44levunqcf7kQvfe2-3s-9ICLREhUomLkus-so?loadFrom=DocumentDeeplink&ts=48.81)): Oh, thank you. It's a great honor to be here and glad to chat with you, Eric. Eric Topol (00:54 (https://www.rev.com/transcript-editor/shared/TeNmzY2C4gOYaZfYSGwxPUyENZYd1G-5AXaZA_S73UFlP-zEdovvYOHIQODXQXZgje0VVgqfNUFX02TeNbOZJEIvhLw?loadFrom=DocumentDeeplink&ts=54.99)): Yeah. Well, I had the real pleasure to hear you speak at a November conference, the AI for Science Forum, which we'll link to your panel (https://youtu.be/SM_vpRtg2Ac). Where I was in a different panel (https://youtu.be/QK_UxXBflvY?si=457e-GejrhLW9l_E), but you spoke about your extraordinary work and it became clear that we need to get you on Ground Truths, so you can tell your story to everybody. So I thought rather than kind of going back from the past where you were in Greece and somehow migrated to Boston and all that. We're going to get to that, but you gave an amazing TED Talk (https://www.ted.com/talks/anna_greka_the_world_s_rarest_diseases_and_how_they_impact_everyone) and it really encapsulated one of the many phenomenal stories of your work as a molecular sleuth. So maybe if you could give us a synopsis, and of course we'll link to that so people could watch the whole talk. But I think that Mucin-1 or MUC1, as you call it, discovery is really important to kind of ground our discussion. A Mysterious Kidney Disease Unraveled Anna Greka (01:59 (https://www.rev.com/transcript-editor/shared/pKNkDbuXpKqi2q2kkVtUXeGql4GyxjCGfjB5Tc0BvS_NUrvR_HiiwLv0G-ObaFDXkPQweH-I6iHeuUn2ktH1oBh1Pqw?loadFrom=DocumentDeeplink&ts=119.28)): Oh, absolutely. Yeah, it's an interesting story. In some ways, in my TED Talk, I highlight one of the important families of this story, a family from Utah, but there's also other important families that are also part of the story. And this is also what I spoke about in London when we were together, and this is really sort of a medical mystery that initially started on the Mediterranean island of Cyprus, where it was found that there were many families in which in every generation, several members suffered and ultimately died from what at the time was a mysterious kidney disease. This was more than 30 years ago, and it was clear that there was something genetic going on, but it was impossible to identify the gene. And then even with the advent of Next-Gen sequencing, this is what's so interesting about this story, it was still…
Not rated yetCarl Zimmer: Air-Borne and the Big Miss With Covid
· 53 min
Before getting into this new podcast, have you checked out the recent newsletter editions and podcasts of Ground Truths? —the first diagnostic immunome (https://erictopol.substack.com/p/the-first-diagnostic-immunome) —a Covid nasal vaccine (https://erictopol.substack.com/p/a-covid-nasal-vaccine-update) update —medical storytelling and uncertainty (https://erictopol.substack.com/p/emily-silverman-storytelling-uncertainty) —why did doctors with A.I. (https://erictopol.substack.com/p/when-doctors-with-ai-are-outperformed) get outperformed by A.I. alone? The audio is available on iTunes and Spotify. The full video is embedded here, at the top, and also can be found on YouTube (https://www.youtube.com/@EricTopolSRTI). Transcript with links to Audio and External Links Eric Topol (00:07 (https://www.rev.com/transcript-editor/shared/uLSuPnNKkzRt94lw4h4d__PrwS561f2IVDa9z-PSJfHT9VGrRt07s4-0CySWzEo8ZbZaLdhftA3My7L_nEYpZoK12f0?loadFrom=DocumentDeeplink&ts=7.26)): Well, hello. It's Eric Topol with Ground Truths, and I am just thrilled today to welcome Carl Zimmer, who is one of the great science journalists of our times. He's written 14 books. He writes for the New York Times and many other venues of great science, journalism, and he has a new book, which I absolutely love called Air-Borne (https://www.penguinrandomhouse.com/books/724793/air-borne-by-carl-zimmer/). And you can see I have all these rabbit pages tagged and there's lots to talk about here because this book is the book of air. I mean, we're talking about everything that you ever wanted to know about air and where we need to go, how we missed the boat, and Covid and everything else. So welcome, Carl. Carl Zimmer (00:51 (https://www.rev.com/transcript-editor/shared/KuDDpkERlP3idWlxAYCUqZIdPRFezvlZdnxTKztnd6VLMPYmxI5HNDWLh5M3-2QhsrF4zjArv4biOD2JWBk-nrcllgo?loadFrom=DocumentDeeplink&ts=51.75)): Thanks so much. Great to be here. A Book Inspired by the Pandemic Eric Topol (00:54 (https://www.rev.com/transcript-editor/shared/sjA1fslJdYyYKOyttCImRKc16MlPEztBQnenkPTXTC7ZfTQXXOWYXYMTtvYYR_D_jAoFaIxKRF8_gvHxr_h-42WDyA0?loadFrom=DocumentDeeplink&ts=54.18)): Well, the book starts off with the Skagit Valley Chorale that you and your wife Grace attended a few years later, I guess, in Washington, which is really interesting. And I guess my first question is, it had the look that this whole book was inspired by the pandemic, is that right? Carl Zimmer (01:18 (https://www.rev.com/transcript-editor/shared/HvohM8RpdavQ_dFlkBu4BOZM_cTfAuI8zH3UjDYkT-BzwJSIB9G1pM65ySi9OqdBmvGTGtRi0V6rxxFNHXs-u2sqL1M?loadFrom=DocumentDeeplink&ts=78.06)): Certainly, the seed was planted in the pandemic. I was working as a journalist at the New York Times with a bunch of other reporters at the Times. There were lots of other science writers also just trying to make sense of this totally new disease. And we were talking with scientists who were also trying to make sense of the disease. And so, there was a lot of uncertainty, ambiguity, and things started to come into focus. And I was really puzzled by how hard it was for consensus to emerge about how Covid spread. And I did some reporting along with other people on this conflict about was this something that was spreading on surfaces or was it the word people were using was airborne? And the World Health Organization said, no, it's not airborne, it's not airborne until they said it was airborne. And that just seemed like not quantum physics, you know what I'm saying? In the sense that it seemed like that would be the kind of thing that would get sorted out pretty quickly. And I think that actually more spoke to my own unfamiliarity with the depth of this field. And so, I would talk to experts like say, Donald Milton at the University of Maryland. I'd be like, so help me understand this. How did this happen? And he would say, well, you need to get to know some people like William Wells. And I said, who? Eric Topol (02:50…
Not rated yetEmily Silverman: Storytelling, Uncertainty, and Humanity in Medicine
· 47 min
Before getting into this new podcast, have you checked out the recent newsletter editions of Ground Truths? —how are gut microbiome drives sugar cravings (https://erictopol.substack.com/p/how-our-gut-microbiome-can-drive) —the influence of sleep on brain waste clearance and aging (https://erictopol.substack.com/p/our-sleep-brain-aging-and-waste-clearance) —the new findings of microplastics in the brain (https://erictopol.substack.com/p/the-microplastic-concerns-elevateto) —the surprise finding about doctors and A.I. (https://erictopol.substack.com/p/when-doctors-with-ai-are-outperformed) In this podcast with Dr. Emily Silverman, an internist and founder ofThe Nocturnists (https://thenocturnists.org/podcast), an award winning podcast and live show, we discuss what inspired her in medicine, what led to her disillusionment, the essentiality of storytelling, of recognizing uncertainty, the limits of A.I., and promoting humanity in medicine. The audio is available on iTunes and Spotify. The full video is linked here, at the top, and also can be found on YouTube (https://www.youtube.com/@EricTopolSRTI). “Storytelling is medicine's currency. Storytelling is not just an act of self-healing; it may actually create better physicians.”—Emily Silverman Transcript with links to audio and relevant publications, websites Eric Topol (00:07 (https://www.rev.com/transcript-editor/shared/YsH-7dD-l4tYzgZ2hTFF_THQQWhOO47iT-tTk6mDCCk3hqADfjQqJnwGtkS9C3dfRWRFaEwJxL3JuaYdCs_RkJZm1oc?loadFrom=DocumentDeeplink&ts=7.62)): Well, hello. This is Eric Topol with Ground Truths, and with me, I am delighted to welcome Dr. Emily Silverman, who is Assistant Volunteer Professor of Medicine at UCSF, an old training grounds for me. And we're going to talk about some of the experience she's had there and she is the Founder of the remarkably recognized podcast, The Nocturnists (https://thenocturnists.org/podcast). It's more than a podcast folks. We'll talk about that too. So Emily, welcome. Emily Silverman (00:40 (https://www.rev.com/transcript-editor/shared/QajS3YB58283bPF-YJ47U9aMrrwjjSVab7fjgummEJVt9ECefPp6hl_pQdKBO8Tzwos0CLO-_Q-jKUozZu9xwThTxBE?loadFrom=DocumentDeeplink&ts=40.38)): Thank you for having me. Inspiration by Kate McKinnon Eric Topol (00:42 (https://www.rev.com/transcript-editor/shared/16eK61x6JNHN3OZnnyfLBhmawAT49Rpgbqdovj8WEZoYkqRt1Cmdi63OsnPKiRudLCaAFYKE_e6I7qdDU8vAwLKLdSc?loadFrom=DocumentDeeplink&ts=42.39)): Yeah. Well, I thought I would go back to perhaps when we first synapsed, and it goes back to a piece you wrote in JAMA about going to the Saturday Night Live (SNL) with Kate McKinnon (https://jamanetwork.com/journals/jama/article-abstract/2738556). And it was one of my favorite columns, of course, it brought us together kind of simpatico because you were telling a story that was very personal, and a surprise factor added to it. We'll link to it. But it said, ‘Sometime in 2016, I fell in love with SNL comedian Kate McKinnon.’ You wrote, ‘It was something about her slow-mo swagger; her unilateral dimple, flickering in and out of existence; the way she drinks up her characters and sweats them from her pores.’ I mean, you're an incredible writer, no less podcast interviewer, organizer, doctor. And you talked about my sterile clinical life, which was kind of maybe a warning of things to come and about the fact that there's two very different career paths, comedy and medicine. One could argue they are in essence the same. So maybe you could tell us about that experience and about Kate McKinnon who, I mean, she's amazing. Emily Silverman (02:09 (https://www.rev.com/transcript-editor/shared/rx-KURM8y0Zj7AxqLzbDpH0EGvluF49IP0UQL0Eti_6QsPfbv8H1-Z8R9orp95C2judlqfcnUiShi79MuqgI0xSQ8Xc?loadFrom=DocumentDeeplink&ts=129.87)): You're making me blush. Thank you for the kind words about the piece and about the writing, and I'm happy to give you a bit of background on that piece and where it came from. So I was in my internal medicine residency…
Not rated yetLotte Bjerre Knudsen: The Scientist Who Drove GLP-1 Drugs For Obesity and Alzheimer's
· 47 min
The Chief Scientific Advisor at Novo Nordisk, Lotte Bjerre Knudsen, was the key force who pushed hard to develop GLP-1 drugs for treating obesity and subsequently for Alzheimer’s. She was recently recognized by the 2024 Lasker Medical Research Award, and the 2024 AAAS Bhaumik Breakthrough of the Year Award. That recognition is richly deserved, since it is unclear if the GLP-1 drug path to obesity treatment, and all of the associated benefits, would have been seen at this time without her influence. That’s especially true given the mystery for why people with Type 2 diabetes (for which these drugs were used for many years) did not exhibit much in the way of weight loss. We discussed that and the future of these drugs, including their potential to prevent neurodegenerative diseases. And about dressing up in pink! The Ground Truths podcasts are also available on Apple and Spotify. Our entire conversation can also be seen by video at YouTube (https://www.youtube.com/watch?v=0imxluNEVgM) along with all of the Ground Truths podcasts (https://www.youtube.com/@EricTopolSRTI). If you like the video format, please subscribe to this channel. Even if you prefer video, please take a look at the transcript with graphics and useful links to citations. A Video Clip below on the barriers of a woman scientist to push Novo Nordisk to develop GLP-1 for obesity. “I was always just been a nerdy little scientist who kind of found home here in this company for 35 years.”—Lotte Bjerre Knudsen, 60 Minutes (https://www.cbsnews.com/news/ozempic-wegovy-sales-inject-wealth-into-novo-nordisk-denmark-60-minutes-transcript/) Transcript with Links to audio and external references Eric Topol (00:06 (https://www.rev.com/transcript-editor/shared/W1wKM4A1jZYQbeOthowRoLP4Vrx2C9fVCxx3QIkUVxQLDxdwfSmEe2MESqjbI5FP1sTnCrNGrEmWLiEMntbG0NVrsf8?loadFrom=DocumentDeeplink&ts=6.87)): Well, hello, it's Eric Topol with Ground Truths, and I have with me a special guest. She's the Chief Science Officer of Novo Nordisk and it's Lotte Bjerre Knudsen, and we're delighted to have her. She's a recent recipient of the Lasker Award (https://laskerfoundation.org/winners/glp-1-based-therapy-for-obesity/), which I think is considered like the pre-Nobel Award here in the United States. And I was involved with her in terms of researching who was the principal person who brought the GLP-1 drugs to the forefront for obesity, and it turned out to be Lotte. So welcome, Lotte. Lotte Bjerre Knudsen (00:48 (https://www.rev.com/transcript-editor/shared/tlotR3hwzpdZmEjxuzAtnWWJsEp4cPgfPV2-W3EnDGvwgXhmkSHC7rKHl1Tn--4_61PPfuu3nTAgj1AfNmA4_T5iPHM?loadFrom=DocumentDeeplink&ts=48.63)): Thank you very much. And also very, very happy to be here. I'm not the Chief Science Officer for Novo Nordisk, I'm the Chief Scientific Advisor of working for the Chief Science Officer of Novo Nordisk, but maybe too many people, not so different, right? From Laundry Detergents to GLP-1 Drugs Eric Topol (01:06 (https://www.rev.com/transcript-editor/shared/c34P2E-tUaxfNnlHXP1uOClDsP8SYugcCFwIPdofWwVo5PXagY5YgdzEg0w3o0LLl0Nhb6KCK0k6v_ZDs6uphuzw4vM?loadFrom=DocumentDeeplink&ts=66.99)): Yes. Thank you, I actually meant to say advisor, but yes, I'm glad you cleared that up. I know from speaking to some of your colleagues, I actually spoke to Robin yesterday that you are looked to very highly, the most highly regarded person in science there, so not surprisingly. What I want to do is first talk about the glucagon-like peptide-1 (GLP-1) that got its legs back in, I guess 1984. So we're going way back. And what's also interesting is that you go way back at Novo Nordisk to 35 years in 1989. And so, there had been this work with this extraordinary hormone and neurotransmitter with a very short half-life that you knew about. But when you first started in Novo Nordisk, you weren't working on this. As I understand it, you're working on laundry detergent enzymes. How did you make this pivot from the laundry enzymes to…
Not rated yetArdem Patapoutian: The Pervasive PIEZO Channels
· 39 min
Piezo touch and pressure-sensing ion channels are showing up everywhere as the explanation for physiologic phenomena, both at the macro and micro levels. Ardem Patapoutian, my friend and colleague at Scripps Research, discovered these receptors back in 2010 and was awarded the Nobel Prize in 2021 for his work. As you’ll see/hear from our conversation, the field has exploded. And you’ll get to know Ardem, who is such a fun, charismatic, and down-to-earth person. He also recently got a unique tattoo (videos below) and I wonder (unlikely) if any other Nobel laureates have one related to their discovery?! Below is a video clip from our conversation. Full videos of all Ground Truths podcasts can be seen on YouTube here (https://www.youtube.com/@EricTopolSRTI). The current one is here (https://youtu.be/Lot-S69RXPw). If you like the YouTube format, please subscribe! The audios are also available on Apple and Spotify. Transcript with links to audio Eric Topol (00:07 (https://www.rev.com/transcript-editor/shared/8Eg1ft3Kv_4iKHJiAgbdIzMMtHkAKQsR7tVXumrJfGlTppE518KRhxQXIagkqEAfLiPaYwcqPI4ivon0pkAw8US8Qkk?loadFrom=DocumentDeeplink&ts=7.05)): Well, hello. It's Eric Topol with Ground Truths, and I've really got a special guest today. The first time for the podcast, I've been able to interview a colleague and faculty at Scripps Research, Ardem Patapoutian, who just by the way happens to be the 2021 Nobel Laureate in Physiology or Medicine (https://www.nobelprize.org/prizes/medicine/2021/patapoutian/biographical/). So welcome, Ardem. It's so wonderful to have you. Ardem Patapoutian (00:30 (https://www.rev.com/transcript-editor/shared/p14hvBBMiVXZ6gscgAfkTD8g3yxc6nOLlaEK7LXWQDLUsCVevWghQWxie12NHeQm-PaKMT83gLQGaJ_rgtvHGcVUo9g?loadFrom=DocumentDeeplink&ts=30.51)): Thanks so much, Eric. Looking forward to chatting with you. Eric Topol (00:34 (https://www.rev.com/transcript-editor/shared/G6L6Ajh9wLiml5SNg7AmK1wJB9syYGnY060R6u2M8tw1bhK2hEJjI-hQ78A049114b1OZ9lDZdvPvBS5HQ2QSFc9zIs?loadFrom=DocumentDeeplink&ts=34.32)): Well, this has been interesting because although I've known you for several years, I didn't research you. I mean, I had to learn about more than I even do. And of course, one of the great sources of that is on the Nobel Prize website where you tell your whole story. (https://www.nobelprize.org/prizes/medicine/2021/patapoutian/biographical/) It is quite a story and not to review all of it, but I wanted to go back just before you made the call to move to Los Angeles from Beirut, Lebanon and with the scare that you went through at that time, it seemed like that was just extraordinary that you had to live through that. Ardem Patapoutian (01:11 (https://www.rev.com/transcript-editor/shared/QJ7Ir2cp5sBcAK8Cx7U-B-Sb-tONXbRXgavp6HNv5453SFtp_pL6UfonJ3229cWdfptuTi75XD0FpYT5m-El1PxIuXs?loadFrom=DocumentDeeplink&ts=71.94)): Yeah, so I am of Armenian origin, but I was born in Lebanon and born in 1967, so I was eight years old when the civil war started. So it's a kind of bizarre childhood in the sense that with all the bombs and fighting in Lebanon. So it was tough childhood to have, but it was never personal. It was bombs and such. And so, the event you're talking about is, I happened to be kidnapped while crossing East to West Beirut. They only held me for four or five hours at first asking me questions to see who I am, but I think they pretty soon figured out that I was not a dangerous guy and they ended up letting me go. But before that, that incident really had a huge impact on me so that by the time I got home, I literally said, I'm out of here. I'm going to find a way to leave the country. And so, that's what, very quickly within a few months I packed and came to United States. Eric Topol (02:19 (https://www.rev.com/transcript-editor/shared/yeUXuuOhegDCAjfCxgex1Qye115peWb_LSESRKKVFHqFi18BNT0o4EGL74h5BuFfKlWFhG5Vax6mej7SHvOdhO0fFJo?loadFrom=DocumentDeeplink&ts=139.2)): And how did you pick LA to be your destination? Ardem…
Not rated yet